ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$283.60 MCurrent assets$4.74 BLiabilities$384.62 MAssets$5.31 BNon-current liabilities$101.02 MEquity$4.92 BGross equity(calculated)$5.82 BNon-current assets$564.41 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSMarketable securitiesCash and cash equivalentsLitigation settlement receivableOther current assetsInvestments measured at fair valueOperating lease right-of-use assetsOther assetsProperty and equipment, netAccrued expensesIncome tax payableAccounts payableOperating lease liabilitiesOther current liabilitiesOperating lease liabilities, noncurrentOther liabilitiesAdditional paid-in capitalAccumulated other comprehensive incomeNoncontrolling interestsCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccrued expensesAccrued expenses$168.74 MIncome tax payableIncome tax payable$74.18 MCurrent liabilitiesCurrent liabilities$283.60 MCurrent assetsCurrent assets$4.74 BAccounts payableAccounts payable$25.08 MLiabilitiesLiabilities$384.62 MOperating lease liabilitiesOperating lease liabilities$12.38 MMarketable securitiesMarketable securities$2.59 BAssetsAssets$5.31 BOther current liabilitiesOther current liabilities$3.21 MNon-current liabilitiesNon-current liabilities$101.02 MOperating lease liabilities, noncurrentOperating lease liabilities, noncurrent$94.77 MEquityEquity$4.92 BOther liabilitiesOther liabilities$6.25 MCash and cash equivalentsCash and cash equivalents$1.25 BGross equity (calculated)Gross equity(calculated)$5.82 BLitigation settlement receivableLitigation settlement receivable$771.63 MOther current assetsOther current assets$128.37 MInvestments measured at fair valueInvestments measured at fair value$444.62 MAdditional paid-in capitalAdditional paid-in capital$5.13 BNon-current assetsNon-current assets$564.41 MOperating lease right-of-use assetsOperating lease right-of-use assets$78.89 MOther assetsOther assets$29.59 MProperty and equipment, netProperty and equipment, net$11.32 MAccumulated other comprehensive incomeAccumulated other comprehensive income$701.00 KNoncontrolling interestsNoncontrolling interests$690.60 MAccumulated deficitAccumulated deficit−$900.35 M
Chart details

ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
5,306,493,000 US dollars
Current assets
4,742,080,000 US dollars
Non-current assets
564,413,000 US dollars
Liabilities
384,624,000 US dollars
Current liabilities
283,603,000 US dollars
Non-current liabilities
101,021,000 US dollars
Equity
4,921,869,000 US dollars
Noncontrolling interest
690,596,000 US dollars. Included in consolidated equity; this amount is not added again.
Marketable securities
2,593,626,000 US dollars
Cash and cash equivalents
1,248,456,000 US dollars
Litigation settlement receivable
771,627,000 US dollars
Other current assets
128,371,000 US dollars
Investments measured at fair value
444,622,000 US dollars
Operating lease right-of-use assets
78,886,000 US dollars
Other assets
29,585,000 US dollars
Property and equipment, net
11,320,000 US dollars
Accrued expenses
168,740,000 US dollars
Income tax payable
74,182,000 US dollars
Accounts payable
25,084,000 US dollars
Operating lease liabilities
12,384,000 US dollars
Other current liabilities
3,213,000 US dollars
Operating lease liabilities, noncurrent
94,768,000 US dollars
Other liabilities
6,253,000 US dollars
Income tax payable, noncurrent
0 US dollars
Additional paid-in capital
5,130,926,000 US dollars
Accumulated other comprehensive income
701,000 US dollars
Common shares, par value $0.0000000341740141 per share, 7,000,000,000 shares authorized and 722,668,062 and 720,352,386 shares issued and outstanding at June 30, 2026 and March 31, 2026, respectively
0 US dollars
Noncontrolling interests
690,596,000 US dollars
Accumulated deficit
negative 900,354,000 US dollars
Gross equity (calculated)
5,822,223,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
ROIVANT SCIENCES LTD. (ROIV) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!